On June 30, 2026, Ari Markinson published the article “Middle-Market Healthcare Deals Facing Tighter State Oversight” in ACG Insights. The following is an excerpt:
Healthcare M&A has always been complex because of the highly regulated nature of the industry. In recent years, a new category of state-level oversight has emerged that is changing how deals move forward in the middle market. State material healthcare transaction review laws, commonly referred to as TRLs, are reshaping timelines, increasing costs, and demanding a level of transparency that sponsors and strategic acquirers have not previously encountered.
For healthcare dealmakers, understanding TRLs has become a front-end diligence and structuring issue, not a back-end compliance exercise.
Click here to access the article.